secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2025-12-10T23:59:59+00:00
Accession:  0001437749-25-037414
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech raises ~$6.8M via warrant exercise inducement, issues new Series G warrants
--------------------------------------------------------------------------------

- Entered inducement letters with holders of Series C/D/F warrants to exercise at $6.63 or $6.3219 per share.
- Company expects aggregate gross proceeds of up to ~$6.8M from the warrant exercises.
- In exchange, issues new Series G warrants to purchase up to 2,610,823 shares (250% of exercised shares) at $6.63, exercisable upon shareholder approval, 5-year term.
- New warrants include anti-dilution price reset with a floor of $1.326 per share and cashless exercise feature.
- Company to file resale registration statement for Series G warrant shares by Jan 8, 2026, seek SEC effectiveness by Feb 9, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925037414/0001437749-25-037414-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925037414/mbrx20251210_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-037414

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer